Larry Kauvar

Dr. Kauvar is the founder and Chief Scientific Officer of Trellis, a company focused on discovery and development of native human monoclonal antibodies for infectious diseases and cancer. He was previously the founder of Telik, a small molecule drug company focused on oncology. He holds 60 US patents for methods, tools and drug compounds. He received a BA in mathematics from Harvard, and a PhD from Yale in molecular biophysics and biochemistry. He conducted postdoctoral research at Caltech and University of California San Francisco before founding Telik.


ISCVID 2017 Conference Account Manager for all conference logistics, programme, sponsorship and exhibition queries:

Tadhg Moriarty
Conference Partners Ltd
T:+353 (0)1 296 8688
E: Conference Organisers


If you require information on the Conference Programme please email your query to:


If you require registration, accommodation assistance please contact a member of the ISCVID 2017 delegate services team:

T: +353 (0)1 296 8688
E: Conference Organisers


To enquire about sponsorship and exhibition packages please contact:

Conference Partners Ltd
T: +353 (0)1 2968688
E: Conference Organisers